About 300 reports

  • Share (Million Yuan)
  • Autoimmunity Diseases Treatment Antibody Sales

Autoimmunity Diseases Treatment Antibody is one important Monoclonal Antibody in China.

  • Autoimmune Disease
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • Share (Million Yuan)
  • Autoimmunity Diseases Treatment Antibody Sales

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for Monoclonal Antibody in China is growing rapidly.

  • Autoimmune Disease
  • Targeted Therapy
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • D) Pemphigus vulgaris
  • F) Cutaneous lupus erythematosus

For example, anti-fibrillin-## antibodies can activate fibroblasts, and antibodies to matrix metalloproteinase-## (MMP-##) and MMP-## can prevent the breakdown of excessive collagen.

  • Autoimmune Disease
  • Cough And Cold
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Psoriasis Therapeutics Market, Competitor Matrix for Psoriasis Marketed and Pipeline Products
  • Psoriasis Therapeutics Market, Global, All Pipeline Products, Phase II, 2018

Alzumab is an anti-CD## monoclonal antibody.

  • Autoimmune Disease
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Novartis AG
  • 2.6.3 Psoriasis

Monoclonal antibodies (mAbs) are the newest class of drugs, predominately used in the treatment of psoriasis.

  • Autoimmune Disease
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Apricus Biosciences, Inc.

TWO MONOCLONAL ANTIBODY (MAB) THERAPIES ARE UNDERGOING CLINICAL TRIALS, ONE OF WHICH IS IN PHASE III.

  • Autoimmune Disease
  • United States
  • Forecast
  • Novartis AG
  • Pfizer Inc.

ELI LILLY' S MIRIKIZIMAB IS A HUMANIZED MONOCLONAL ANTIBODY THAT SELECTIVELY BINDS TO THE P## SUBUNIT UNIQUE TO CYTOKINE IL-##, NEUTRALIZING ITS ACTIVITY.

  • Autoimmune Disease
  • Cough And Cold
  • AbbVie Inc.
  • Pfizer Inc.
  • Remicade group
  • ABBREVIATIONS

Riken LY-## LYC-## LYC-## MaaT-## melittin menadione sodium bisulfite mesalamine MGL-## Monoclonal Antibodies to Antagonize Metallothioneins for Ulcerative Colitis and Crohn' s Disease Monoclonal Antibodies to Antagonize TGF-Beta Receptor Type-

  • Autoimmune Disease
  • Cough And Cold
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

The later stages of clinical development for HS are dominated by monoclonal antibodies and oral small molecule drugs.

  • Autoimmune Disease
  • United States
  • World
  • Forecast
  • AbbVie Inc.
  • MARKET CHALLENGES

These are large and complex molecules extracted from biologic sources such as proteins, DNA vaccines, and monoclonal antibodies.

  • Autoimmune Disease
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • GLOBAL PSORIASIS MARKET - PHASE III DRUGS (INJECTABLE BIOLOGICS) PIPELINE (COLLECTIVE) FORECAST - 2028 ($ BN)

TREGALIZUMAB IS ANOTHER HIGH-RISK PHASE II INVESTIGATIONAL DRUG, AN ANTI-CD## MONOCLONAL ANTIBODY, INDUCING SELECTIVE ACTIVATION OF REGULATORY T-CELLS.

  • Autoimmune Disease
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.

TABLE ##. ##.

  • Autoimmune Disease
  • World
  • Forecast
  • Market Size
  • MicroBiome Therapeutics LLC

It is a human monoclonal antibody against interleukin ## receptor.

  • Autoimmune Disease
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • D) Inflammatory bowel disease

This segment consists largely of premium systemic monoclonal antibodies (mAb), which are highly commercially successful due to their widespread use and high cost.

  • Autoimmune Disease
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Psoriasis Market by Segment, U. S., 2014 – 2024 (US

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • World

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Ulcerative Colitis Market by Segment, U. S., 2014 –

  • Autoimmune Disease
  • Medical Biotechnology
  • Therapy
  • United States
  • World

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Ankylosing Spondylitis Market by Segment, U. S., ##

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • World

Some of these biologics are approved and used in more than one conditions.

  • Autoimmune Disease
  • Medical Biotechnology
  • Therapy
  • United States
  • World

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Rheumatoid Arthritis Market by Segment, U. S., 2014

  • Autoimmune Disease
  • Pathology
  • Therapy
  • United States
  • Market Size
  • KEY COMPANIES IN THE ULCERATIVE COLITIS MARKET IN THE 7MM, 2015

IT IS GUT-SELECTIVE MONOCLONAL ANTIBODY AND HAS SUPERIOR SAFETY PROFILE COMPARED TO ANTI-TNFS.

  • Autoimmune Disease
  • Market Size
  • EA Pharma Co., Ltd.
  • Pfizer Inc.
  • Remicade group

It is an antiinflammatory monoclonal antibody, which is currently in its Phase II stage of clinical trials and is being evaluated for the treatment of moderate to severe Crohn' s disease.

  • Autoimmune Disease
  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • GLOBAL IMMUNOSUPPRESSANTS MARKET

In September 2017, the company' s monoclonal antibody, TECENTRIQ, was approved by the European Union.

  • Autoimmune Disease
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

Number of Psoriatic Arthritis Drugs in Early-Stage Development by Molecule Type Synthetic Peptide Recombinant Protein Monoclonal Antibody Conjugated Fusion Protein Small Molecule Monoclonal Antibody Discovery Number of Drugs Phase I Preclinical Perspective THERE A

  • Autoimmune Disease
  • United States
  • AbbVie Inc.
  • Celgene Corporation
  • Pfizer Inc.

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Rheumatoid Arthritis Market by Segment, U. S., 2014

  • Anti Rheumatic
  • Autoimmune Disease
  • Medical Biotechnology
  • Therapy
  • United States

Retail Pharmacies ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Figure ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. (## of ##) ## Chart ## ##: Drug Prices - Retail Vs Veteran, 2017, U. S. ## Figure ## ##: Crohn’s Disease Market by Segment, U. S., 2014 – ##

  • Autoimmune Disease
  • Monoclonal Antibody
  • Pathology
  • Therapy
  • United States

Some of these biologics are approved and used in more than one conditions.

  • Autoimmune Disease
  • Medical Biotechnology
  • Therapy
  • United States
  • Market Size

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade
  • PRE-CLINICAL MOLECULES

The drug candidate is a subcutaneously administered monoclonal antibody.

  • Autoimmune Disease
  • Amgen Inc.
  • Coherus BioSciences, Inc.
  • Mycenax
  • Pfizer Inc.

Monoclonal antibodies are monospecific as clones of a single parent produce them.

  • Autoimmune Disease
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc